University of Tennessee - Memphis is a clinical research site located in Memphis, Tennessee, United States 38163.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Tennessee - Memphis has participated in 4 clinical trials.
Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Biogen.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Tennessee - Memphis has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Tennessee - Memphis has 4 clinical trials on record. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Yes — University of Tennessee - Memphis holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.